<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592955</url>
  </required_header>
  <id_info>
    <org_study_id>EYEMUST-2</org_study_id>
    <nct_id>NCT01592955</nct_id>
  </id_info>
  <brief_title>Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU)</brief_title>
  <official_title>Glaucoma Treatment by Cyclo-coagulation Using High Intensity Focused Ultrasound With the EyeOP1 Medical Device.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeTechCare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>EyeTechCare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness and the safety of the
      cyclocoagulation using High Intensity Focused Ulatrsound with the EYEOP1 device in glaucoma
      patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy endpoint : Success / failure rate at 1 year</measure>
    <time_frame>12 months</time_frame>
    <description>IOP change (mm Hg and percent) from baseline to 12 months post-HIFU treatment. (Success defined by IOP reduction &gt; 20% compared to the baseline IOP or IOP &lt; 21 mmHg)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety measures</measure>
    <time_frame>12 months</time_frame>
    <description>Number of device and procedure-related and others complications during follow-up</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>EYEOP1 device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>cyclocoagulation HIFU</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EYEOP1</intervention_name>
    <description>Cyclocoagulation using High Intensity Focused Ultrasound with EYEOP1 device</description>
    <arm_group_label>EYEOP1 device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Refractory Glaucoma

          -  IOP &gt; 21 mm Hg

          -  No previous intraocular surgery or laser treatment during the 90 days before HIFU day

          -  Age &gt; 18 years

          -  Informed consent sgned by the subject

        Exclusion Criteria:

          -  Normal Tension Glaucoma

          -  Glaucoma drainage device implanted and still present in the eye to be treated

          -  History of ocular or retrobulbar tumor

          -  Ocular infection within 14 days prior to the HIFU procedure

          -  Aphakic patient

          -  Ocular disease other than glaucoma that may affect assessment of visual and/or IOP
             (choroidal hemorrhage or detachment, lens subluxation, thyroid ophthalmopathy,
             proliferative diabetic retinopathy, clinical significant macular edema)

          -  Pregnant or breast-feeding women, or lack of contraception use among women likely to
             have a child
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent FARCY</last_name>
    <role>Study Director</role>
    <affiliation>EyeTechCare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Sam Rothberg Glaucoma Center, Goldschleger EyeInstitute, Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Paolo</name>
      <address>
        <city>Milano</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute Ophthalmology - Universita di Parma</name>
      <address>
        <city>Parma</city>
        <zip>43121</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinica Oculistica Universitaria - P-O Oftalmico</name>
      <address>
        <city>Torino</city>
        <zip>10149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Genève</name>
      <address>
        <city>Genève</city>
        <zip>CH-1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de Montchoisi - Glaucoma center</name>
      <address>
        <city>Lausanne</city>
        <zip>CH-1006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>Italy</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <results_reference>
    <citation>Melamed S, Goldenfeld M, Cotlear D, Skaat A, Moroz I. High-intensity focused ultrasound treatment in refractory glaucoma patients: results at 1 year of prospective clinical study. Eur J Ophthalmol. 2015 Nov-Dec;25(6):483-9. doi: 10.5301/ejo.5000620. Epub 2015 May 13.</citation>
    <PMID>25982212</PMID>
  </results_reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>June 15, 2015</last_update_submitted>
  <last_update_submitted_qc>June 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Cyclocoagulation</keyword>
  <keyword>HIFU High Intensity Focused Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

